Cargando…
Intracellular Autofluorescence as a New Biomarker for Cancer Stem Cells in Glioblastoma
SIMPLE SUMMARY: Since glioblastoma stem cells (GSCs) have paramount roles in tumor initiation, progression, recurrence, and therapy resistance, innovative approaches to specifically identify and isolate GSCs in a straightforward manner would be invaluable both for clinical and scientific application...
Autores principales: | Vieira de Castro, Joana, S. Gonçalves, Céline, P. Martins, Eduarda, Miranda-Lorenzo, Irene, T. Cerqueira, Mariana, Longatto-Filho, Adhemar, A. Pinto, Afonso, L. Reis, Rui, Sousa, Nuno, Heeschen, Christopher, M. Costa, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920313/ https://www.ncbi.nlm.nih.gov/pubmed/33669350 http://dx.doi.org/10.3390/cancers13040828 |
Ejemplares similares
-
Cadherin‐3 is a novel oncogenic biomarker with prognostic value in glioblastoma
por: Martins, Eduarda P., et al.
Publicado: (2022) -
The Fuss Over Lipo“fuss”cin: Not All Autofluorescence is the Same
por: Sainz, B., et al.
Publicado: (2015) -
A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis
por: Gonçalves, Céline S., et al.
Publicado: (2020) -
WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma
por: Gonçalves, Céline S., et al.
Publicado: (2018) -
Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy
por: Afonso, Julieta, et al.
Publicado: (2023)